Viking Therapeutics’ stock soars 61% premarket after company reports positive results in trial of weight-loss drug

Post Content

Previous post Lowe’s beats earnings estimates as sales fall — and the company expects revenue to slide again this year
Next post Macy’s beats earnings expectations and unveils plan to boost growth, which includes closing stores and selling assets